NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD & NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS

- Results from a randomized Phase IIb trial reported at 2009 ASCO Annual Meeting - MISSISSAUGA, ON, June 1 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE Amex: YMI , TSX:YM, AIM:YMBA), a life sciences product development company that identifies and advances a diverse portfolio ...

Quark Pharmaceuticals Presented At ARVO Data Showing That PF-04523655 Enters Retinal Cells And Elicits Its Pharmacologic Effect Via Target Gene Knock-Down Without Activating TLR3

FREMONT, Calif., May 11 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing novel RNA interference (RNAi)-based therapeutics, today announced that Elena Feinstein, M.D., Ph.D., Chief Scientific Officer, presented a study titled, "PF-04...

Northwest Biotherapeutics Settles Class Action Complaint, and SEC Investigation Closed Without Action

BETHESDA, Md., Jan. 8 /PRNewswire-FirstCall/ -- Northwest Biotherapeutics, Inc. (OTC Bulletin Board: NWBO; AIM: NWBS and NWBT) (the "Company" or "NWBT") announced today settlement of a putative securities class action lawsuit, In re Northwest Biotherapeutics, Inc. Securities Litigation , No. C-...

In the Midst of International Economic Crisis, VidaCura Offers a Helping Hand to Those Without Insurance

VidaCura.com helps consumers save money on home medical and wellness products FARMINGTON, Conn., Oct. 15 /PRNewswire/ -- VidaCura, Incorporated, today announced the launch of its online health and wellness store, VidaCura.com. VidaCura.com provides a comprehens...

ASCO 2008: Tumor-Targeted Rexin-G Demonstrates Dose-Dependent Anti-Tumor Activity Without Toxicity in Metastatic Pancreatic Cancer

SAN MARINO, Calif., May 19 /PRNewswire/ -- Epeius Biotechnologies announced today the results of an on-going Phase I/II study of Rexin-G for metastatic pancreatic cancer (Chawla et al., ASCO meeting, 2008). Continuing on with the planned dose-escalations of Rexin-G which began in 2005 using lo...

Nasal Vaccine for Smallpox Confers High Levels of Immunity Without Safety Risks

Data published in February issue of Clinical and Vaccine Immunology ANN ARBOR, Mich., Feb. 26 /PRNewswire/ -- Scientists at NanoBio Corporation and the University of Michigan have demonstrated their nasally delivered vaccinia vaccine can protect animals against 77 times the potentially letha...

Good Neighbor Pharmacy(R) Ironman Competitor Inspires Individuals with Diabetes to Live Without Limits

'Iron Andy' Holder Completes First Year Inspiring Others to Manage Chronic Conditions VALLEY FORGE, Pa., Jan. 17 /PRNewswire/ -- In 2007, Good Neighbor Pharmacy(R) featuring Diabetes Shoppe(R), teamed up with "Iron Andy" Holder as part of the "Managing Diabetes: Li...

Possible New Way to Detect, Monitor Liver Disease Without Painful Liver Biopsy

Hepatitis B Foundation says discovery suggests earlier treatment could benefit patients DOYLESTOWN, Pa., Dec. 19 /PRNewswire/ -- Scientists working at the Hepatitis B Foundation, in partnership with Drexel University College of Medicine, think they may have discover...

Amazing Treatment Relieves Serious Back Pain Without Dangerous Drugs, Injections or Surgery!

CHICAGO, Dec. 14 /PRNewswire/ -- Non-surgical, spinal decompression is probably the last back pain treatment you will ever need. And you can forget about popping toxic pills, struggling through exercise programs...and...unnecessary and risky injections and surgery...because with this amazing t...

ANX-514 Reduces Hypersensitivity Reactions Without Impacting Pharmacokinetics or Antitumor Activity in Preclinical Tests

ADVENTRX Presents Results at 2007 AACR-NCI-EORTC International Conference SAN DIEGO, Oct. 25 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: ANX ), a biopharmaceutical research and development company focused on commercializing proprietary product candidates for the treatment o...

Treatment blocks pain without disrupting other functions

A combination of two drugs can selectively block pain-sensing neurons in rats without impairing movement or other sensations such as touch, according to a new study by National Institutes of Health (NIH)-supported investigators. The finding suggests an improved way to treat pain from childbirth a...

Using catalysts to stamp nanopatterns without ink

DURHAM, N.C. Using enzymes from E. coli bacteria, Duke University chemists and engineers have introduced a hundred-fold improvement in the precision of features imprinted to create microdevices such as labs-on-a-chip. Their inkless microcontact printing technique can imprint details measuring ...

FRC Applauds New Ballot Initiative for Cures Without Cloning

Missourians Introduce New Ballot Initiative to Pursue Cures for Patients, without involving controversial Human Cloning WASHINGTON, Aug. 22 /PRNewswire-USNewswire/ -- Today, a new grassroots ballot initiative was launched in Missouri to ensure that taxpayer funds support cures for p...

A Race without a Finish Line!

When times get difficult, its the companies who dont panic, that will continue to grow and serve their customers. About ten years ago, I was working on a project for the Council for Continuous Improvement (CCI), a non-profit organization based in San Jose, California. I was arranging and conductin...

Style Without Substance: Will HTML Email Survive Abuse?

While Internet pop-up windows exhale a dying breath, HTML-based email messages find themselves glimpsing a similar fate. Surveys in 2003 are showing that plain text email messages are becoming more popular, and more successful, than HTML counterparts. A July 10, 2003, Lucid Marketing survey ...

Encrypted data without the fuss

Milwaukee PKWare s new server-based file compression software has come out of beta testing for its public release, touting the ability to create encrypted self-extracting files in the companys Zip format and run on several platforms. Recipients of the files can now open them without needin...

Succeeding online without a Web site

Conducting business online has been a struggle for businesses that don't adapt easily to an environment driven by online transactions and corporate branding. Local businesses such as restaurants and stores find themselves outfunded, outstaffed and outmarketed online by larger competitors. P...

Researchers report development of embryonic stem cells without destroying embryo

A Massachusetts company, working with University of Wisconsin-Madison researchers and others, says it has discovered a way to generate embryonic stem cell lines without interfering with the developmental potential of the embryos. The company, Advanced Cell Technology, Inc. of Worcester, Mass.,...

Some Madisonians content without city wireless

Madison, Wis. - Madison's five-month-old citywide wireless Internet system has some growing to do, especially when it comes to reaching coffee shop regulars. Mad City Broadband , a division of Georgia-based Cellnet Technology, Inc., manages Madison's Wi-Fi system, which was launched in the do...

Wisconsin won't get Georgia biotech without a fight

Madison, Wis. - Wisconsin officials and investors who are trying to come up with the financing that will enable a Georgia life science firm to relocate here have a fight on their hands. And that's because Georgia is not simply willing to let go of Aruna Biomedical , an Athens, Ga. business th...

DHC 2007: Without fuller IT adoption, health costs might drain America's wealth

Madison, Wis. - If the pace of healthcare information technology adoption doesn't pick up soon, the United States could reach an unsustainable situation regarding healthcare costs, according to John Wade, who delivered the keynote address Wednesday at Digital Healthcare Conference 2007 . With...

Detection of Morphine and Morphine-Glucuronide in Saliva or Urine with a Rapid and Simple Method Without Derivatization on the Varian 500-MS

Jason S. Wood, Ph.D. Varian, Inc. Introduction Testing for drugs of abuse (DoA) is becoming more prevalent in various environments, including forensics and social justice environments as well as in sporting events. Non-heroin opiates such as morphine, oxycodone, and...

Measuring Gene Silencing Effects by RT-PCR Without RNA Isolation

Perform RT-PCR Directly in Cell Lysates Using Cells-to-cDNA II Quantitative or real time RT-PCR is one of the most commonly used techniques for quantitating changes in gene expression across samples. When working with cell ...

KV Pharmaceutical Announces Stockholder Action to Amend By-Laws is Invalid

...ements that address expectations or projections about the future, including without limitation, product development, product launches, regulatory approvals, ma...parties against products sold by the Company or its subsidiaries, including without limitation the litigation and claims referred to in Note 16 of the Notes to...

Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product

...ties and other important factors could cause the Company's actual results to differ materially from those in the forward-looking statements including, without limitation, current economic conditions, foreign currency fluctuations, risks associated with the Company's continued research and development efforts...

Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results

...t cash to complete the analysis of the results from our cocaine trial and methamphetamine study and to continue our operations through the end of 2010 without additional funding," said Patrick J. McEnany, Catalyst's Chief Executive Officer. "We believe that our financial and human resources are sufficient to...

Onyx Pharmaceuticals Announces Pricing of Concurrent Offerings of Four Million Shares of Common Stock and $200 Million Principal Amount of Convertible Senior Notes

...elease also contains "forward-looking statements" of Onyx within the meaning of the federal securities laws. These forward-looking statements include without limitation, statements regarding expectations as to completion and timing of any public offering. These statements are subject to risks and uncertain...

Synthetech Reports First Quarter Fiscal 2010 Results

...ng of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, are forward-looking, including, without limitation, statements regarding: future operating results; market conditions and opportunities; the timing and amount of shipments; the resolution of...

InterMune Reports Second Quarter 2009 Financial Results and Business Highlights

...ties Exchange Act of 1934, as amended, that reflect InterMune's judgment and involve risks and uncertainties as of the date of this release, including without limitation the statements related to anticipated product development timelines and the likelihood of regulatory success. All forward-looking statement...

deCODE genetics Announces Webcast of Conference Call to Discuss Second Quarter 2009 Financial Results

...effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10-K and any updates to those risk factors filed from time to time in...

Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC-305

...tatement: This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including without limitation the Company's statements regarding: the expected timing and amount of payments to be received by Curis under the license agreement with Deb...

Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009

...f subjects, was defined as placement of the filter without subsequent pulmonary embolism, significant filter ...ate restenosis rates of DES's in patients with and without diabetes in a real-world setting. The article repo...is for patients with diabetes as compared to those without diabetes. Data for both the Cypher and Endeavor st...

Repligen Reports First Quarter Fiscal Year 2010 Financial Results

...this press release which are not strictly historical statements, including, without limitation, statements regarding current or future financial performance an...ause actual results to differ materially from those anticipated, including, without limitation, risks associated with: the success of current and future collab...

Cell Therapeutics Second Quarter Net Loss Decreases 54%; Pixantrone NDA Submitted to the FDA for Approval

...l, and with OPAXIO, pixantrone, and brostallicin, in particular, including, without limitation, the potential failure of these product candidates to prove safe...time in our filings with the Securities and Exchange Commission, including, without limitation, our most recent filings on Forms 10-K, 10-Q and 8-K. Except as ...

PDI Reports 2009 Second Quarter Financial Results

...statements are subject to the risk factors detailed from time to time in PDI's periodic filings with the Securities and Exchange Commission, including without limitation, PDI's Annual Report on Form 10-K for the year ended December 31, 2008, and PDI's subsequently filed quarterly reports on Form 10-Q and cur...

Amicus Therapeutics Announces Second Quarter 2009 Financial Results

...l results may differ materially from those set forth in this release due to the risks and uncertainties inherent in the business of Amicus, including, without limitation: the potential inability to reach final agreement with regulatory agencies on the lifting of the clinical hold on the AT2220 program; the p...

Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results

...lts may differ materially from those set forth in this press release due to the risks and uncertainties inherent in the company's business, including, without limitation: the company's dependence on its only product candidate, Acetavance, and the possibility that the FDA may determine that the data and infor...

Pharmasset to Present at Canaccord Adams Conference

...studies designed to assess the potential of combinations of small molecules without Pegasys(R) and Copegus(R) to treat chronic HCV. These clinical studies are ...forward-looking statements" that involve risks and uncertainties, including without limitation, the risk that adverse events could cause the cessation or delay...

GeoVax Labs, Inc. Provides Clinical Studies Update

...ot intend to do so. Certain matters discussed in this news release are forward-looking statements involving certain risks and uncertainties including, without limitation, risks detailed in the Company's Securities and Exchange Commission filings and reports. For more information on GeoVax Labs, Inc...

Optimer Pharmaceuticals Reports Second Quarter 2009 Financial Results

...a description of historical facts are forward-looking statements, including without limitation all statements related to the development of fidaxomicin and pru...ue to the risks and uncertainties inherent in Optimer's business including, without limitation, risks relating to: the timing, progress and likelihood of succe...